KA

Kumar Amitabh

Director DIN 03511599
DIN 03511599 First appointment Jun 2011
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jun 2011
Shareholding value β€’β€’β€’β€’ Premium profile

About Kumar Amitabh

Data last updated:

Kumar Amitabh was a Director at Aeramic Health Care Private Limited (from 2019) and Managing Director at Bellis Biotech Private Limited (from 2011).

DIN 03511599
First Appointment 29 Jun 2011
Oldest Company Age 15 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aeramic Health Care Private Limited U24100DL2019PTC347214
Director13 Mar 20192019Strike Off
Bellis Biotech Private Limited U51109KA2011PTC059385
Managing Director29 Jun 20112011₹33.4 Lakh (FY 2016)Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Aeramic Health Care Private Limited
Bellis Biotech Private Limited
Premium access

Shareholding and investment profile for Kumar Amitabh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kumar Amitabh

Kumar Amitabh was first appointed on 29 Jun 2011 as Managing Director at Bellis Biotech Private Limited. The most recent appointment on record is 13 Mar 2019 at Aeramic Health Care Private Limited.

Kumar Amitabh held 2 earlier board appointments: Aeramic Health Care Private Limited (Director, from 13 Mar 2019); Bellis Biotech Private Limited (Managing Director, from 29 Jun 2011).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available